Scarica l'app Stockscreener
195.87
3.30%
6.26
Pre-mercato:
196.75
0.88
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$189.61
Aprire:
$188.67
Volume 24 ore:
4.84M
Relative Volume:
1.19
Capitalizzazione di mercato:
$138.62B
Reddito:
$24.57B
Utile/perdita netta:
$3.60B
Rapporto P/E:
38.78
EPS:
5.051
Flusso di cassa netto:
$5.26B
1 W Prestazione:
+1.95%
1M Prestazione:
+4.56%
6M Prestazione:
-4.52%
1 anno Prestazione:
+3.78%
Intervallo 1D:
$188.06
$196.51
Intervallo di 1 settimana:
$188.06
$198.56
Portata 52W:
$180.03
$242.80
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
195.87 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
514.23 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
574.00 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
117.50 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
324.68 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DHR Maintained by Goldman Sachs -- Price Target Lowered to $230 - GuruFocus
The Goldman Sachs Group Lowers Danaher (NYSE:DHR) Price Target to $230.00 - MarketBeat
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes - PR Newswire
Best Biotech Stocks To Keep An Eye OnApril 12th - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
What to expect from Danaher Corporation's Q1 2026 earnings report - MSN
Massachusetts Financial Services Co. MA Boosts Stake in Danaher Corporation $DHR - MarketBeat
Factory Mutual Insurance Co. Sells 5,500 Shares of Danaher Corporation $DHR - MarketBeat
Bar Harbor Wealth Management Has $14.72 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Promising Biotech Stocks To Follow TodayApril 10th - MarketBeat
GENERAL AMERICAN INVESTORS CO INC's Danaher Corp(DHR) Holding History - GuruFocus
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Douglas Lane & Associates LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Published on: 2026-04-10 13:38:44 - baoquankhu1.vn
Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance UK
Masimo stock price target raised to $180 by Jefferies on Danaher deal - Investing.com Australia
Danaher Corporation $DHR Stock Holdings Cut by CCLA Investment Management - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Support Test: Whats the beta of Danaher Corporation stockQuarterly Trade Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Biotech Stocks To Keep An Eye OnApril 8th - MarketBeat
Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape - Markets Mojo
Danaher (NYSE:DHR) Given New $230.00 Price Target at Wolfe Research - MarketBeat
Jefferies Financial Group Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price - MarketBeat
9,123 Shares in Danaher Corporation $DHR Purchased by Oak Thistle LLC - MarketBeat
Sivik Global Healthcare LLC Trims Stock Holdings in Danaher Corporation $DHR - MarketBeat
GREENWOOD CAPITAL ASSOCIATES LLC's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation $DHR Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List - Insider Monkey
Biotech Stocks To Watch NowApril 7th - MarketBeat
Evaluating Danaher (DHR) After Mixed Recent Returns And Conflicting Undervaluation Signals - simplywall.st
Fulton Breakefield Broenniman LLC Reduces Stock Holdings in Danaher Corporation $DHR - MarketBeat
The Osterweis Fund's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation (DHR) Stock Price, News, Quote & History - ca.finance.yahoo.com
Danaher (DHR) Analyst Rating: Evercore ISI Lowers Price Target | - GuruFocus
Best Biotech Stocks To ConsiderApril 6th - MarketBeat
Danaher Corporation (DHR) Stock Forecasts - Yahoo Finance
Danaher: After a Long Reset Period, Profit Growth Looks Likely to Accelerate in the Medium Term - Morningstar
Evercore Cuts Danaher (NYSE:DHR) Price Target to $225.00 - MarketBeat
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors (DHR) - Seeking Alpha
What to Expect From Danaher Corporation's Q1 2026 Earnings Report - Barchart
Rathbones Group PLC Has $60.78 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Major Investors Accumulate Danaher Shares Amid Price Weakness - AD HOC NEWS
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):